Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Gastroenterol. latinoam ; 20(4): 261-267, oct.-dic. 2009. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-673452

RESUMO

The inflammatory bowel diseases (IBD) like Crohn‘s disease (CD) and Ulcerative colitis (UC) requires prolonged treatments. Frequently a low adherence is observed and affects the prognosis and quality of life of these patients. Aim: Assess the medical indications in patients with IBD and their impact on disease progression. Methods: A retrospective study of patients with IBD admited in the University Hospital of the University of Chile between January and December 2006. Results: We included a total of 41 hospitalized patients (35 UC and 5 CD), being 27 of them (66 percent) due to relapse, 7 due the debut of their illness (17 percent), 3 by the need of surgery and 4 patients for other causes (10 percent). Among the patients with relapses, half presented low adherence to treatment. With regard to ambulatory management it was found insufficient doses, indication of permanent use of steroids and/or patients without treatment in a 52 percent. During hospitalization, 8 percent of patients were treated with non-steroidal anti-inflammatory drug (NSAID) and 23 percent of them did not receive indication of folic acid or calcium at discharge. In the treatment after discharge, 14 percent of the patients received indication of prolonged steroid therapy. Regarding outcome, 35 percent of patients presented a new crisis and 22 percent needed hospitalization for a new reactivation of IBD. Conclusion: Our study confirms an inadequate management of patients with IBD in ambulatory and hospitalized scenario. Only a better understanding of the IBD by patients and medical team will optimize the treatment improving their prognosis and outcome of the disease.


Las Enfermedades Inflamatorias Intestinales (EII) como la Enfermedad de Crohn (EC) y la Colitis Ulcerosa (CU) requieren tratamientos prolongados. Por otro lado, suelen tener una baja adherencia que afecta el pronóstico y la calidad de vida de estos pacientes. Objetivo: Evaluar las indicaciones médicas que recibieron los pacientes y su repercusión en la evolución de la enfermedad. Método: Estudio retrospectivo de pacientes con diagnóstico de EII hospitalizados en el Hospital Clínico de la Universidad de Chile, entre Enero y Diciembre de 2006. Resultados: Se incluyó un total de 41 pacientes (36 CU y 5 EC), siendo 27 de ellos (66 por ciento) hospitalizados por recaídas, 7 por debut de su enfermedad (17 por ciento), 3 por necesidad de cirugía (7 por ciento) y 4 por otras causas (10 por ciento). Dentro de los pacientes con recaídas, la mitad presentaba una mala adherencia al tratamiento. En cuanto al manejo ambulatorio, se encontró dosis insuficientes, uso de esteroides a permanencia y/o pacientes sin tratamiento en un 52 por ciento de los ingresos. Durante la hospitalización, un 8 por ciento fue tratado con antiinflamatorios no esteroidales (AINES) y un 23 por ciento de ellos no recibió indicación de ácido fólico o calcio al momento del alta. Durante el tratamiento post hospitalario, un 13,8 por ciento de los pacientes mantuvo la indicación de esteroides a permanencia. En cuanto a la evolución posterior, el 35 por ciento de los pacientes presentó una nueva crisis y un 22 por ciento requirió una nueva hospitalización por reactivación de su EII. Conclusión: Nuestro estudio confirma un manejo inadecuado de los pacientes con EII tanto en su tratamiento ambulatorio como intrahospitalario. Una mayor comprensión de las EII por parte de los pacientes y del equipo médico, permitiría optimizar el tratamiento de estas patologías mejorando su pronóstico y evolución.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Adulto Jovem , Doenças Inflamatórias Intestinais/terapia , Assistência Ambulatorial , Colite Ulcerativa/terapia , Cooperação do Paciente , Doença de Crohn/terapia , Estudos Retrospectivos , Evolução Clínica , Hospitalização
2.
Rev. méd. Chile ; 137(2): 255-258, feb. 2009. tab
Artigo em Espanhol | LILACS | ID: lil-516091

RESUMO

Background: Restless legs syndrome (RLS) is a neurological condition that is characterized by the irresistible urge to move the legs and is very common. In the last decade, much attention has been focused on RLS, given its high occurrence, underdiagnosis, and impact on quality of Ufe. Aim: To determine the frequency of RLS in a neurologic-psychiatric outpatient clinic. Patients and Methods: We interviewed patients attending a prívate neurological outpatient clinic, using a standardized validated questionnaire, and an additional phone interview to confirm diagnosis. Results: Of approximately 800 people attending the clinic, the questionnaire was answered by 238 subjects (168 females). Fifteen percent of respondents were affected by RLS and none had been diagnosed before. Most patients had a severe form that probably required treatment. Conclusions: A low awareness of RLS exists in Chile, even among specialized physicians.


Assuntos
Adulto , Feminino , Humanos , Masculino , Síndrome das Pernas Inquietas/diagnóstico , Instituições de Assistência Ambulatorial/estatística & dados numéricos , Distribuição de Qui-Quadrado , Chile/epidemiologia , Neurologia , Psiquiatria , Inquéritos e Questionários , Síndrome das Pernas Inquietas/epidemiologia , Síndrome das Pernas Inquietas/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA